You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 135 No. 4, April 1981 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Second Malignancy in Acute Lymphocytic Leukemia

Review of 33 Cases

LTC Askold D. Mosijczuk, MC; COL Frederick B. Ruymann, MC

Am J Dis Child. 1981;135(4):313-316.


Abstract

• Improved survival in childhood cancer resulting from advances in therapy is frequently associated with long-term morbidity, including the potential for second malignancy. In a review of the literature in the English language, we found 33 cases of acute lymphocytic leukemia (ALL) followed by a second neoplasm. Second tumors in this group of patients with ALL include seven cases of histiocytic medullary reticulosis, four cases of Hodgkin's disease, nine cases of acute myelocytic leukemia, four cases of chronic myelocytic leukemia, and nine cases of solid tumors. The appearance of subsequent malignancies may be related to a combination of therapy-induced immunosuppression, a direct carcinogenic effect resulting from therapy, and/or constitutional factors. Physicians should be alert to the possibility of subsequent malignant neoplasms in survivors of cancer.

(Am J Dis Child 1981;135:313-316)



Author Affiliations

USA; USA

From the Division of Pediatric Hematology-Oncology, Fitzsimons Army Medical Center, Aurora, Colo (Dr Mosijczuk) and Walter Reed Army Medical Center, Washington, DC (Dr Ruymann).


Footnotes

The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting the views of the Department of the Army or Department of Defense.

Reprint requests to Section of Pediatric Hematology-Oncology, Fitzsimons Army Medical Center, Aurora, CO 80045 (Dr Mosijczuk).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983
Bhatia et al.
Blood 2002;99:4257-4264.
ABSTRACT | FULL TEXT  

The Tan Tonsil Sign: A Clinical Marker of Lymphoproliferative Disease
Cunningham and Eavey
CLIN PEDIATR 1992;31:237-240.
 

Malignant Histiocytosis After Lymphoblastic Lymphoma
Kim et al.
Arch Pediatr Adolesc Med 1983;137:474-476.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1981 American Medical Association. All Rights Reserved.